Food News and Research

RSS

FDA approves advanced malignant melanoma drug

Maxim Pharmaceuticals today announced that its treatment protocol to provide its investigational drug Ceplene(TM), in combination with interleukin-2 (IL-2), for the treatment of patients with advanced malignant melanoma, has been approved by the U.S. Food and Drug Administration (FDA).

14 Apr 2004

$Pittsburgh eye center to offer refractive procedure for presbyopia$

Pittsburgh eye center to offer refractive procedure for presbyopia

UPMC Eye Center has become one of the first in Allegheny County to offer conductive keratoplasty (CK) for presbyopia. Recently approved by the U.S. Food and Drug Administration (FDA), it is the first and only FDA-approved vision technology that improves near vision in the millions of baby boomers with presbyopia, the age-related eye condition that sets in after age 40.

14 Apr 2004

More Americans allergic to seafood than any other food

A new study released today at the American Academy of Allergy, Asthma & Immunology annual conference shows that food allergies are a much more pervasive health challenge than once thought. About 11 million people -- roughly 1-in-25 Americans -- are now believed to be affected by one or more food allergies, a disease triggered by the ingestion or contact with certain foods that may cause life-threatening reactions, or anaphylaxis, according to The Food Allergy & Anaphylaxis Network (FAAN), a co-investigator of the nationwide survey.

13 Apr 2004

Foreign drug repackager complies with FDA order

The Food and Drug Administration today announced the settlement of a court case against an Illinois firm involved last year in FDA's seizure of thousands of imported unapproved drugs, including those that were labeled in foreign languages and/or labeled as repacked.

13 Apr 2004

FDA makes moves to block foreign drug imports

The Food and Drug Administration today announced a new partnership with the Virginia Pharmacists Association to distribute consumer educational materials outlining the risks of purchasing medicines outside of FDA’s regulatory scope. Over the past month, FDA has co-sponsored agreements with state pharmacists associations in Illinois, California, Texas, Maryland, New York, and Nebraska, and the Agency anticipates that additional agreements will be signed in the weeks ahead.

13 Apr 2004

UK Health Minister joins top chef to taste-test hospital food

UK Health Minister, Lord Warner joined forces with celebrity chef, Lloyd Grossman, today, to choose which dishes should appear on hospital menus across England as part of the Better Hospital Food programme.

13 Apr 2004

Coronary stent drives Johnson & Johnson to record profits

Johnson & Johnson today announced sales for the first quarter of $11.6 billion, an increase of 17.7% over the prior year. The increase represented operational growth of 12.3% and a currency impact of 5.4%. Domestic sales were up 15.1%, while international sales increased 21.8%, including operational growth of 7.8% and a positive currency impact of 14.0%.

13 Apr 2004

Allergies cost UK £1 billion per annum

Researchers from the Universities of Edinburgh and Aberdeen and St George’s Medical School in London say one in five children and adults in Britain suffer from allergies, with annual health services treatment bill running at £1billion. They call for more allergy specialists to meet the increased demand.

13 Apr 2004

FDA makes final ruling on dietary supplements containing ephedrine alkaloids

The Food and Drug Administration (FDA) announced today that the final rule on dietary supplements containing ephedrine alkaloids is effective immediately.

12 Apr 2004

Vitamin E appears to cut in half people's risk of bladder cancer

Getting plenty of vitamin E by eating foods like nuts and olive oil appears to cut in half people's risk of bladder cancer, the fourth leading cancer killer among men, a new study suggests.

12 Apr 2004

FDA approval of stomach acid suppressant

Wyeth Pharmaceuticals, a division of Wyeth, has announced that the U.S. Food and Drug Administration (FDA) approved the reformulation of the stomach acid suppressant, PROTONIX(R) I.V. (pantoprazole sodium) for Injection.

12 Apr 2004

Process to minimize the side effect of painful arthritis

The University of Missouri Friday announced the discovery of a process to minimize the side effect of painful arthritis that develop after knee surgeries. The procedure will be tested in human clinical trials this summer if the process is approved by the Food and Drug Administration, the Columbia, Mo-based school said.

12 Apr 2004

Household molds trigger allergic rhinitis

April showers can increase the amount of mold found inside and outside the home. Along with pollens from trees, grasses, and weeds, molds are an important trigger of allergic rhinitis, affecting nearly 40 million Americans, according to the American Academy of Allergy, Asthma & Immunology (AAAAI).

12 Apr 2004

FDA issues warning againts street drug alternatives

FDA issued a warning in February 2004, about adverse events experienced by four teenagers after they consumed Green Hornet Liquid that contained high levels of the over-the-counter drugs diphenhydramine and dextromethorphan.

11 Apr 2004

FDA claims high levels of lead in Mexican candy

The Food and Drug Administration (FDA) has announced that it is aware of a problem associated with lead contamination of some Mexican candy products being sold in the United States and is suggesting that parents, care providers and other responsible individuals do not allow children to eat these products at this time.

11 Apr 2004

Ephedra - herbal stimulant sales illegal as of Monday

Sales of the herbal stimulant ephedra become illegal in the United States on Monday, barring a last-minute reprieve from a federal judge.

11 Apr 2004

Natural medication shown to not always be a safe alternative to synthetic medication

The common perception that if medication is natural then it must be safe has recently come under fire from a researh by a Consumer Reports magazine. The consumer publication found a dozen herbal supplements, some banned in Asia, Europe and Canada but widely available in the United States, may cause cancer, kidney or liver damage and even death.

10 Apr 2004

Indevus announces agreement with Pliva for overactive bladder treatment drug

Indevus Pharmaceuticals, Inc. has announced that it has entered into a co-promotion and licensing agreement with PLIVA d.d. through its specialty branded subsidiary, Odyssey Pharmaceuticals Inc., for the U.S. commercialization of SANCTURA™ (trospium chloride), under review by the U.S. Food and Drug Administration (FDA) as a treatment for overactive bladder.

10 Apr 2004

Australian symposium on stroke and head injury

A condition which leaves some stroke and head injury victims unable to see half their world will be the subject of a one-day symposium being hosted by Southern Cross University (SCU) this week.

10 Apr 2004

Low carb diets should be avoided by growing children and adolescents

Even if you're not eating "low-carb," it's a good bet you at least know several people who are. Many people have found this the way to lose and maintain weight, while others argue that although you may see results, it could ultimately cause health problems such as heart disease. Most pediatricians would agree that a low-carb diet is not one a growing child should embrace.

9 Apr 2004